In The News 02/07

According to a study of 7,736 osteoporotic women (average age 73) reported by the American Society for Bone and Mineral Research, an annual injection of 5 mg of zoledronic acid reduced vertebral fractures by 75 percent, hip fractures by 40 percent and nonvertebral fractures by 25 percent at the end of three years.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access